Denali Therapeutics Inc. DNLI Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on trailing twelve months.
The official record: Denali Therapeutics Inc.’s 10-Q, filed August 11, 2025, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s free cash flow margin?
- Denali Therapeutics Inc. (DNLI) reported free cash flow margin of -31,736.3% in Q2 2024.
- How has Denali Therapeutics Inc.'s free cash flow margin changed year-over-year?
- Denali Therapeutics Inc.'s free cash flow margin decreased by 33799.1% year-over-year, from -93.6% to -31,736.3%.
- What is the long-term trend for Denali Therapeutics Inc.'s free cash flow margin?
- Over 3 years (2020 to 2023), Denali Therapeutics Inc.'s free cash flow margin has grown at a -3.0% compound annual growth rate (CAGR), from 123.1% to -112.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.